U.S. Topical Pain Relief Market by Therapeutic Class (Non-Opioids and Opioids), Formulation (Cream, Gel, Spray, Patch, and Others), Type (Prescription Pain Relief and Over-the-Counter Pain Relief), and Distribution Channel (Pharmacies & Drug Stores, E-Commerce, and Retail & Grocery Stores): Opportunity Analysis and Industry Forecast, 2020–2027
- ALL4209148
- 128 Pages
- January 2021
- Medical Devices
Pain is a distressing feeling caused by intense or damaging stimuli and it is one of the most common reasons for physician consultation in the U.S. Analgesics or painkillers are used to reduce and treat body pain. Whenever these analgesics are applied directly to the skin they are known as topical pain relief medications. These include topical administration of drugs such as non-steroidal anti-inflammatory drugs, anesthetics, capsaicin, and opioids. Topical pain relief medications exert peripheral effects near the site of application and minimize the pain.
Increase in prevalence of arthritis and joint pain is the major factor that contributes toward the growth of the topical pain relief market in the U.S. Moreover, other factors that fuel the market growth include growth in geriatric population, lesser side effects caused due to use of topical analgesics as compared to oral pain relief, wide availability of topical pain relieving drugs, and high demand for topical pain relief by sports players. However, topical pain relief medications can cause irritated skin and they have a strong odor or unpleasant smell that impede the market growth. Conversely, development of online platform for the topical therapeutics is expected to provide lucrative opportunities for the market growth.
The U.S. topical pain relief market is segmented into therapeutic class, type, formulation, and distribution channel. On the basis of therapeutic class, the market is bifurcated into non-opioids and opioids. The non-opioids segment is further divided into nonsteroidal anti-inflammatory drugs (NSAIDS), methyl salicylate, capsaicin, lidocaine, and other non-opioids. The opioids segment is further bifurcated into buprenorphine and fentanyl. On the basis of type, the market is segmented into prescription pain relief and over-the-counter (OTC) relief. On the basis of formulation, the market is classified into cream, gel, spray, patch, and others. The distribution channels covered in the study include pharmacies & drug stores, e-commerce, and retail & grocery stores
KEY BENEFITS FOR STAKEHOLDERS
• The study provides an in-depth analysis of the market along with the current trends and future estimations to elucidate the imminent investment pockets.
• It offers a quantitative analysis from 2019 to 2027, which is expected to enable the stakeholders to capitalize on the prevailing market opportunities.
• A comprehensive analysis of factors that drive and restrain the growth of the market is provided.
• The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook of the market.
KEY MARKET SEGMENTS
By Therapeutic Class
• Non-opioids
o Nonsteroidal anti-inflammatory drug (NSAIDS)
o Methyl Salicylate
o Capsaicin
o Lidocaine
o Other Non-opioids
• Opioids
o Buprenorphine
o Fentanyl
By Formulation
• Cream
• Gel
• Spray
• Patch
• Others
By Type
• Prescription Pain Relief
• Over-the-counter (OTC) Pain Relief
By Distribution Channel
• Pharmacy & Drug Store
• e-Commerce
• Retail & Grocery Store
LIST OF KEY PLAYERS PROFILED IN THE REPORT
• AdvaCare Pharma
• GlaxoSmithKline plc (GSK)
• Johnson & Johnson
• Nestlé S.A.
• Novartis AG
• Pfizer Inc.
• Reckitt Benckiser Group plc
• Sanofi S.A.
• Sun Pharmaceutical Industries Ltd.
• Topical BioMedics, Inc.
LIST OF OTHER PLAYERS IN THE VALUE CHAIN (These players are not profiled in the report. The same will be included on request.)
• Cipla Limited
• Glenmark Pharmaceuticals Limited
1.1.Report description
1.2.Key benefits for stakeholders
1.3.Key market segments
1.4.Research methodology
1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.Key findings of the study
2.2.CXO perspective
CHAPTER 3:MARKET OVERVIEW
3.1.Market definition and scope
3.2.Key findings
3.2.1.Top investment pockets
3.3.Porter’s five force analysis
3.4.Market dynamics
3.4.1.Drivers
3.4.1.1.Increase in prevalence of arthritis
3.4.1.2.Growth in geriatric population
3.4.1.3.High demand for topical pain relief products by sportsperson
3.4.1.4.Lesser side effects caused by topical pain relief products as compared to oral medicines
3.4.2.Restraints
3.4.2.1.Topical pain relief sometimes cause skin irritants
3.4.2.2.Topical pain relief is characterized by unpleasant odor
3.4.3.Opportunities
3.4.3.1.Emergence of online pharmacy
3.4.4.Impact analysis
3.5.COVID-19 Impact analysis on U.S. topical pain relief market
CHAPTER 4:U.S. TOPICAL PAIN RELIEF MARKET, BY THERAPEUTIC CLASS
4.1.Overview
4.1.1.Market size and forecast
4.2.Non-opioids
4.2.1.Key market trends, growth factors and opportunities
4.2.2.Market size and forecast, by type
4.2.2.1.Nonsteroidal anti-inflammatory drugs (NSAIDS)
4.2.2.1.1.Market size and forecast
4.2.2.2.Methyl salicylates
4.2.2.2.1.Market size and forecast
4.2.2.3.Capsaicin
4.2.2.3.1.Market size and forecast
4.2.2.4.Lidocaine
4.2.2.4.1.Market size and forecast
4.2.2.5.Other non-opioids
4.2.2.5.1.Market size and forecast
4.3.Opioids
4.3.1.Key market trends, growth factors and opportunities
4.3.2.Market size and forecast, by type
4.3.2.1.Buprenorphine
4.3.2.1.1.Market size and forecast
4.3.2.2.Fentanyl
4.3.2.2.1.Market size and forecast
CHAPTER 5:U.S. TOPICAL PAIN RELIEF MARKET, BY FORMULATION
5.1.Overview
5.1.1.Market size and forecast
5.2.Cream
5.2.1.Market size and forecast
5.3.Gel
5.3.1.Market size and forecast
5.4.Spray
5.4.1.Market size and forecast
5.5.Patch
5.5.1.Market size and forecast
5.6.Others
5.6.1.Market size and forecast
CHAPTER 6:U.S. TOPICAL PAIN RELIEF MARKET, BY TYPE
6.1.Overview
6.1.1.Market size and forecast
6.2.Prescription pain relief
6.2.1.Market size and forecast
6.3.Over-the-counter pain relief
6.3.1.Market size and forecast
CHAPTER 7:U.S. TOPICAL PAIN RELIEF MARKET, BY DISTRIBUTION CHANNEL
7.1.Overview
7.1.1.Market size and forecast
7.2.Pharmacies & drug stores
7.2.1.Market size and forecast
7.3.E-Commerce
7.3.1.Market size and forecast
7.4.Retail & grocery stores
7.4.1.Market size and forecast
CHAPTER 8:COMPANY PROFILES
8.1.ADVACARE PHARMA
8.1.1.Company overview
8.1.2.Company snapshot
8.1.3.Operating business segments
8.1.4.Product Portfolio
8.2.GLAXOSMITHKLINE PLC (GSK)
8.2.1.Company overview
8.2.2.Company snapshot
8.2.3.Operating business segments
8.2.4.Product portfolio
8.2.5.Business performance
8.2.6.Key strategic moves and developments
8.3.JOHNSON & JOHNSON
8.3.1.Company overview
8.3.2.Company snapshot
8.3.3.Operating business segments
8.3.4.Product portfolio
8.3.5.Business performance
8.4.NESTLÉ S.A.
8.4.1.Company overview
8.4.2.Company snapshot
8.4.3.Operating business segments
8.4.4.Product Portfolio
8.4.5.Business performance
8.5.NOVARTIS AG
8.5.1.Company overview
8.5.2.Company snapshot
8.5.3.Operating business segments
8.5.4.Product portfolio
8.5.5.Business performance
8.6.PFIZER INC.
8.6.1.Company overview
8.6.2.Company snapshot
8.6.3.Operating business segments
8.6.4.Product portfolio
8.6.5.Business performance
8.7.RECKITT BENCKISER GROUP PLC
8.7.1.Company overview
8.7.2.Company snapshot
8.7.3.Operating business segments
8.7.4.Product Portfolio
8.7.5.Business performance
8.8.SANOFI
8.8.1.Company overview
8.8.2.Company snapshot
8.8.3.Operating business segments
8.8.4.Product portfolio
8.8.5.Business performance
8.9.SUN PHARMACEUTICAL INDUSTRIES LTD.
8.9.1.Company overview
8.9.2.Company snapshot
8.9.3.Operating business segments
8.9.4.Product portfolio
8.9.5.Business performance
8.10.TOPICAL BIOMEDICS, INC.
8.10.1.Company overview
8.10.2.Company snapshot
8.10.3.Operating business segments
8.10.4.Product Portfolio
TABLE 01.U.S. TOPICAL PAIN RELIEF MARKET, BY THERAPEUTIC CLASS, 2019–2027 ($MILLION)
TABLE 02.U.S. TOPICAL NON-OPIOIDS MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 03.U.S. TOPICAL OPIOIDS MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 04.U.S. TOPICAL PAIN RELIEF MARKET, BY FORMULATION, 2019–2027 ($MILLION)
TABLE 05.U.S. TOPICAL PAIN RELIEF MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 06.U.S. TOPICAL PAIN RELIEF MARKET, BY DISTRIBUTION CHANNEL, 2019–2027 ($MILLION)
TABLE 07.ADVACARE: COMPANY SNAPSHOT
TABLE 08.ADVACARE: BUSINESS SEGMENTS
TABLE 09.ADVACARE: PRODUCT PORTFOLIO
TABLE 10.GSK: COMPANY SNAPSHOT
TABLE 11.GLAXOSMITHKLINE PLC.: OERATING SEGMENT
TABLE 12.GLAXOSMITHKLINE PLC.: PRODUCT PORTFOLIO
TABLE 13.GSK: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 14.J&J: COMPANY SNAPSHOT
TABLE 15.J&J: OPERATING SEGMENTS
TABLE 16.J&J: PRODUCT PORTFOLIO
TABLE 17.NESTLÉ: COMPANY SNAPSHOT
TABLE 18.NESTLÉ: OPERATING SEGMENTS
TABLE 19.NESTLÉ: PRODUCT PORTFOLIO
TABLE 20.NOVARTIS: COMPANY SNAPSHOT
TABLE 21.NOVARTIS: OPERATING SEGMENT
TABLE 22.NOVARTIS: PRODUCT PORTFOLIO
TABLE 23.PFIZER: COMPANY SNAPSHOT
TABLE 24.PFIZER: OPERATING SEGMENT
TABLE 25.PFIZER: PRODUCT PORTFOLIO
TABLE 26.RB: COMPANY SNAPSHOT
TABLE 27.RB: OPERATING SEGMENTS
TABLE 28.RB: PRODUCT PORTFOLIO
TABLE 29.SANOFI: COMPANY SNAPSHOT
TABLE 30.SANOFI: OPERATING SEGMENT
TABLE 31.SANOFI: PRODUCT PORTFOLIO
TABLE 32.SUN PHARMA: COMPANY SNAPSHOT
TABLE 33.SUN PHARMA: OPERATING SEGMENTS
TABLE 34.SUN PHARMA: PRODUCT PORTFOLIO
TABLE 35.TOPICAL BIOMEDICS: COMPANY SNAPSHOT
TABLE 36.TOPICAL BIOMEDICS: OPERATING SEGMENTS
TABLE 37.TOPICAL BIOMEDICS: PRODUCT PORTFOLIO
Similar Reports
This report provides an overview of the French molecular diagnostic testing market, including test volume, and sales forecasts by Application, 2019-2023, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
This report provides an overview of the German molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...
- Publish Date: April 1, 2019
- $450
This report provides an overview of the Italian molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...
- Publish Date: April 1, 2019
- $450
